Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...

Scientists at St. Jude Children's Research Hospital have reconciled two closely related but contentious mechanisms underlying ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

Founded by Fapon Group and Dr. Wesselhoeft (Orna Therapeutics), MOTE is taking aim at one of RNA's most persistent challenges: cell-specific delivery beyond the liver. MOBILIZE LNPs use a bifunctional ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

A recent study reveals that slowing down the intracellular transport of RNA-based drugs can significantly enhance their ...

A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.